Straight answers

We are a health and wellness company with three lines: skin care, nutritional supplements, and an AI-assisted home nursing platform. They are run by different specialists and held to one shared standard of evidence, sourcing and safety.

Because the same household needs all three, usually at the same time. Keeping them under one standard means the person buying a serum and the daughter arranging care for her mother are dealing with the same company and the same commitments.

AVÉLORA Group is based in New York, United States, and works with manufacturing, laboratory and care partners in several markets. Enquiries from other regions are welcome.

No. We do not test on animals and we require the same commitment from our suppliers and manufacturing partners.

An independent laboratory with no commercial interest in the outcome verifies identity, potency and contaminant limits on the finished batch — not only on the raw material, and not only in our own facility. Results are tied to the batch code on the pack.

Some categories — retinoids in particular — are generally avoided during pregnancy. Please check with your physician or midwife before starting or continuing any active product, and tell them the specific ingredients involved.

They can, meaningfully. Speak to your physician or pharmacist before combining supplements with prescription medicines, especially anticoagulants, thyroid medication, antibiotics and antidepressants.

Availability is announced by line as each range completes testing and release. If you would like to be told when a specific category launches, send us a note and we will contact you directly rather than adding you to a mailing programme you did not ask for.

No. It is a care-support and monitoring system. It does not diagnose, does not give medical advice, and is not a replacement for emergency services or professional clinical judgement.

Presence, movement, environmental and event data required for the agreed care purpose — not imagery in private spaces. Access is granted by role to the family members and care staff the household nominates, with a record of who accessed what.

Yes. Households and care organisations both start with a scoped pilot, and there is a defined exit at the end of it. Care technology that can only be evaluated after a long contract is not worth evaluating.

Yes, in all three cases, and we also develop private-label ranges for selected partners. Details are on our partnerships page.

We aim to reply to every enquiry within two business days. Partnership and safety enquiries are prioritised.

English and Chinese. Write in whichever you prefer — you will be answered in the same language.